Effects of a ketamine metabolite on synaptic NMDAR function

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study

(2016) Jaskaran B. Singh et al.   BIOLOGICAL PSYCHIATRY

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

(2016) Panos Zanos et al.   NATURE

Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses

(2014) E. S. Gideons et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Age dependence of the rapid antidepressant and synaptic effects of acute NMDA receptor blockade

(2014) Elena Nosyreva et al.   Frontiers in Molecular Neuroscience

Acute Suppression of Spontaneous Neurotransmission Drives Synaptic Potentiation

(2013) E. Nosyreva et al.   JOURNAL OF NEUROSCIENCE

Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors

(2012) Ruin Moaddel et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

(2011) Anita E. Autry et al.   NATURE

Memantine binding to a superficial site on NMDA receptors contributes to partial trapping

(2009) Shawn E. Kotermanski et al.   JOURNAL OF PHYSIOLOGY-LONDON

Spontaneous and Evoked Glutamate Release Activates Two Populations of NMDA Receptors with Limited Overlap

(2008) D. Atasoy et al.   JOURNAL OF NEUROSCIENCE